Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994b. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):487-495.

Allen, B.C., P.L. Strong, C.J. Price, S.A. Hubbard, and G.P. Daston. 1996. Benchmark dose analysis of developmental toxicity in rats exposed to boric acid. Fundam. Appl. Toxicol. 32(2):194-204.

Alles, A.J., and K.K. Sulik. 1989. Retinoic-acid-induced limb-reduction defects: Perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology 40(2):163-171.

Alon, U., N. Barkai, D.A. Notterman, K. Gish, S. Ybarra, D. Mack, and A.J. Levine. 1999. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 96(12):6745-6750.

Alonso-Aperte, E., N. Ubeda, M. Achon, J. Perez-Miguelsanz, and G. Varela-Moreiras. 1999. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 52(4):750-756.

Amsterdam, A., S. Burgess, G. Golling, W. Chen, Z. Sun, K. Townsend, S. Farrington, M. Haldi, and N. Hopkins. 1999. A large-scale insertional mutagenesis screen in zebrafish. Genes. Dev. 13(20):2713-2724.

Anderson, N.G., and L. Anderson. 1982. The Human Protein Index. Clin. Chem. 28(4 Pt. 2):739-748.

Anderson, N.L., and N.G. Anderson. 1998. Proteome and proteomics: New technologies, new concepts, and new words. Electrophoresis 19(11):1853-1861.

Andrews, J.E., M. Ebron-McCoy, U. Bojic, H. Nau, and R.J. Kavlock. 1995. Validation of an in vitro teratology system using chiral substances: Stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos. Toxicol. Appl. Pharmacol. 132(2):310-316.

Andrews, J.E., M.T. Ebron-McCoy, U. Bojic, H. Nau, and R.J. Kavlock. 1997. Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture. Teratology 55(5):314-318.

Arman, E., R. Haffner-Krausz, Y. Chen, J.K. Heath, and P. Lonai. 1998. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. U.S.A 95(9):5082-5087.

Artavanis-Tsakonas, S., M.D. Rand, and R.J. Lake. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284(5415):770-776.

Baggs, R.B., R.K. Miller, and C.L. Odoroff. 1991. Carcinogenicity of diethylstilbestrol in the Wistar rat: effect of postnatal oral contraceptive steroids. Cancer Res. 51(12):3311-3315.

Bailey, A., A. Le Couteur, I. Gottesman, P. Bolton, E. Simonoff, E. Yuzda, and M. Rutter. 1995. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol. Med. 25(1):63-77.

Baker, N.E., and S.Y. Yu. 1997. Proneural function of neurogenic genes in the developing Drosophila eye. Curr. Biol. 7(2):122-132.

Baker, K., K.S. Warren, G. Yellen, and M.C. Fishman. 1997. Defective “pacemaker” current (Ih) in a zebrafish mutant with a slow heart rate. Proc. Natl. Acad. Sci. U.S.A. 94(9):4554-4559.

Baldwin, H.S., and M. Artman. 1998. Recent advances in cardiovascular development: Promise for the future. Cardiovasc. Res. 40(3):456-468.

Bantle, J.A., R.A. Finch, D.T. Burton, D.J. Fort, D.A. Dawson, G. Linder, J.R. Rayburn, M. Hull, M. Kumsher-King, A.M. Gaudet-Hull, and S.D. Turley. 1996. FETAX interlaboratory validation study: Phase III—Part 1 testing. J. Appl. Toxicol. 16(6):517-528.

Barber, C.V., and A.G. Fantel. 1993. The role of oxygenation in embryotoxic mechanisms of three bioreducible agents. Teratology 47(3):209-223.

Bargmann, C.I. 1998. Neurobiology of the Caenorhabditis elegans genome. Science 282(5396):2028-2033.

Bargmann, C.I., and I. Mori. 1997. Chemotaxis and termotaxis. Pp. 717-737 in C. elegans II, D.L. Riddle, T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. Plainview, NY: Cold Spring Harbor Laboratory Press.